Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot Trial of huJ591 in Progressive Androgen-Independent Prostate Cancer
NCT00024232Phase 2Completed
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- Jun 2001
- Primary completion
- Feb 2004
- Modality
- Engineered Antibody Formats, Antibody-Radionuclide Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of huJ591 in prostate cancer (PCa), sponsored by Memorial Sloan Kettering Cancer Center. Started Jun 2001; status: completed.
02
Drugs
huJ591
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00024232.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00024232.